483
Emergent BioSolutions Canada Inc.FDA 483 - Emergent BioSolutions Canada Inc. - May 10, 2022
Record Details
An FDA inspection of Emergent BioSolutions Canada Inc. in Winnipeg, MB, revealed significant deficiencies in their manufacturing processes. The observations primarily concern inadequate procedures to prevent microbial contamination, issues with aseptic processing using a Vanrx system, and insufficient laboratory controls for samples. These findings indicate potential risks to product sterility and quality.
View Company Profile
ID · 0712f356-7635-47ec-bb53-1d16f00681a6
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.